Abbott Laboratories reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 9,964 million compared to USD 9,747 million a year ago. Net income was USD 1,225 million compared to USD 1,318 million a year ago.

Diluted earnings per share from continuing operations was USD 0.7 compared to USD 0.75 a year ago.